Journal article
Preclinical Multimodality Imaging in Vivo.
- Stout DB Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, The David Geffen School of Medicine at UCLA, 570 Westwood Plaza, CNSI Building, Room 2151, Los Angeles, CA 90095, USA.
- Zaidi H Division of Nuclear Medicine, Geneva University Hospital, CH-1211 Geneva, Switzerland. Electronic address: habib.zaidi@hcuge.ch.
- 2016-05-10
Published in:
- PET clinics. - 2008
English
Multimodality small-animal molecular imaging has become increasingly important as transgenic and knockout mice are produced to model human diseases. With the ever-increasing number and importance of human disease models, particularly in rodents (mice and rats), the ability of high-resolution multimodality molecular imaging instrumentation to contribute unique information is becoming more common and necessary. Multimodality imaging with high spatial resolution and good sensitivity, which combines modalities and records sequentially or simultaneously complementary information, offers many advantages in certain research experiments. This article discusses the current trends and new horizons in preclinical multimodality imaging in-vivo and its role in biomedical research.
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.1016/j.cpet.2009.03.001
- PMID 27156661
- Persistent URL
- https://sonar.ch/global/documents/103301
Statistics
Document views: 32
File downloads: